Comprehensive Care after Myocardial Infarction (CCMI): Long-Term Investment in the Health of Polish Citizens.

CCMI model cardiac rehabilitation cardiovascular disease prevention comprehensive cardiac care myocardial infarction secondary prevention

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 06 2022
Historique:
received: 17 05 2022
revised: 15 06 2022
accepted: 15 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

The comprehensive care model after myocardial infarction (CCMI, in Polish: KOS-Zawał) has been in effect continuously since October 2017. Within the bundle of services financed by the Polish National Health Fund (NHF), patients receive a diagnosis, conservative and invasive treatment, early cardiac rehabilitation and follow-up visits for 12 months. The existing model of managing patients after myocardial infarction (MI) implements all crucial aspects of care recommended by the European Society of Cardiology (ESC), emphasised many times. The purpose of this paper was to report and describe the course of the implementation of the unique concept-CCMI model, including the scope of the introduced changes and the implementation and structural evaluation of its effects over the period 2017-2021. Our preliminary study reported that the CCMI programme reduces the risk of patient death in the first year after MI by 29%. Furthermore, the authors point out the strict cause and effect relationship between the cardiovascular disease prevention programme since 2004 as the key instrument for the primary systemic prevention implemented outside the CCMI model.

Identifiants

pubmed: 35742767
pii: ijerph19127518
doi: 10.3390/ijerph19127518
pmc: PMC9224417
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Kardiol Pol. 2013;71(9):995-1003
pubmed: 24065281
Arch Med Sci. 2019 Jun 06;16(3):551-558
pubmed: 32399102
Kardiol Pol. 2022;80(3):415-321
pubmed: 35129204
Arch Med Sci. 2022 Mar 17;18(3):569-576
pubmed: 35591826

Auteurs

Grzegorz Kubielas (G)

Department of Nursing and Obstetrics, Faculty of Health Sciences, Wroclaw Medical University, 51-618 Wrocław, Poland.
Department of Health Care Services, Central Office, Polish National Health Fund, 02-528 Warsaw, Poland.

Paulina Hydzik (P)

Department of Nursing and Obstetrics, Faculty of Health Sciences, Wroclaw Medical University, 51-618 Wrocław, Poland.

Łukasz Rypicz (Ł)

Department of Population Health, Faculty of Health Sciences, Wroclaw Medical University, 50-372 Wrocław, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH